Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties. (Q33811661)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties. |
scientific article |
Statements
Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties (English)
Tromm A
Griga T
1 November 1999